投資先としてのベルギー：ライフサイエンス分野
The case of Eurogentec S.A., investment in Life Sciences sector
Hitoshi YAHARA
Officer
General Manager
QOL Division
矢原均
理事
ＱＯＬ事業部長
株式会社カネカ
12 May, 2015
Belgium–Japan Joint Seminar
Corporate Profile
Name
KANEKA CORPORATION
President
Mamoru Kadokura
Date of
establishment
September 1, 1949
Financial Structure
(as of March 31,2014)
Paid-in Capital 33,046 million yen *
Net Sales
524,785 million yen *
Number of
employees
8,907 *
(consolidated basis)
Head Office
Osaka, Tokyo
* (as of March 31,2014)
2
Activities in Life Science Field
Expand business fields
with many subsidiaries.
Regenerative Medicine
-
Bio Master
Bone Marrow MSC
Separation Device
Programmable Closed
Circuit Cell Culture system
Fat Stem Cell Therapy
-
Medical Devices
Functional Foods
-
-
Coenzyme Q10
Reduced Coenzyme Q10
Others
-
Plasmapheresis Treatment
System
Selective adsorption column
PTCA Catheter
Bio-Pharma related
business
Fine Chemicals
DDS
(Patient Friendly Drug)
-
-
RSMs
GMP Intermediates
Transdermal Products
Unique Oral Dosage Form
KM
Transderm
APIs
- CMO Services
- Generic APIs
Mab discovery support
Protein A resin
IVD Products
cGMP BioManufacturing
Genomics and Proteomics
Eurogentec
Anaspec
Gene
Frontier
OSCL
3
Kaneka’s History in Belgium
4
Eurogentec Located in the Heart of Europe
Eurogentec S.A.
• 4 manufacturing sites
– 2 in Belgium
– 2 in California, USA
– GMP Biologics facility in
Belgium
• Employees: 325
• Manufacturing
– Custom research reagents
– IVD oligonucleotides
– GMP Biopharmaceuticals
5
Eurogentec Business
Development and Contract Manufacturing of
Innovative solutions for Life Science research
Reliable components for Diagnostic field
Biologics for Therapeutic applications
Life Science Research
Diagnostic Services
GMP BioManufacturing
Products and Services
Manufacturing Solutions
Proteins, Plasmids, Vaccines
Solution Provider for Life
Science Research & Biotech
Companies
cGMP Compliant
Manufacturer for Clinical
and Commercial Phases
6
Two Manufacturing Business Units
Genomics
Proteomics
10 500 m² of labs and offices in LIEGE SCIENCE Park (Belgium) and FREMONT (USA)
Life Science Research products and services
Oligonucleotides
PCR and qPCR Kits & Reagents
Ultra Pure Taq Polymerases
Fluorophores and Quenchers
Assay Dispensing Services
Antibodies
Peptides
Assay Kits
Biologics
Multipurpose cGMP facilities
GMP Manufacturing for
clinical stage and market
Process Development, Validation
and Transfer
Clinical & Commercial
Manufacturing
Drug Substance/Product Release
Diagnostics : manufacturing of key components
cGMP Oligonucleotides
cGMP Taq Polymerase
Antibodies
GMP
7
Eurogentec’s History
2013, 2014 FDA successful routine inspection
2011
EGT became a part of Kaneka
Acquisition of AnaSpec Inc., CA
2010
2009
2008
2004
Creation of EGT North America
FDA successful pre-approval for
inspection for commercial
manufacturing
2001
2000
ISO 13485 Certification of IVD
GMP Oligonucleotides
manufacturing in Liege (BE)
Start of GMP manufacturing of
IVD Oligonucleotides in Liège
ISO 9001 Certification
1996 CMO for the biopharmaceutical sector
1995 Peptides Synthesis
1994 GMP Production Facility accredited by Belgian Health Authorities
1985
1987
Oligonucleotides Synthesis
Foundation
8
Vision for the Future
Aspiration is to become the world’s leading company in biomanufacturing
business through collaboration between Eurogentec and Kaneka
Kaneka’s Features
Eurogentec’s Features
High quality standards in
products and services
Long experience in
biomanufacturing
Longstanding customer
relationship
High quality facilities and
equipments
Innovative and experienced
R&D
Vision
To become the
world’s leading
company in
biomanufacturing
business
Sufficient financial resources
Strong relationship with big
Pharma
Experiences in other life
science business
e.g., Medical device
Broad business portfolio
9
What makes Wallonia
industrial-academic innovation
network successful is:
The proximity (geography and
mental) of the partners
The capacity to go get the best
know-how where it lies
A very good academic system
that nurture education level
and an "industrial mind"
A very good expertise in
"innovation" process from
research to "product/service"
development and company
creation and management
Examples of collaboration between
Eurogentec and University of Liege
Biologics
DNAVAC – a Biowin project
RECOINS – a public private
partnership project
REWARD – a BEWARE fellowships
academia project
ROBOTEINE – an Equip2013
project
MycAvert – a WB health project
Life Science Products and Services
Quantified peptides for MS detection
Universal standard for protein
identification and quantification
Beta-cells in vivo detection
Optimization of Eurogentec’s
products
10
ご静聴ありがとうございました。
Thank you for your attention.
11